Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$2.29
-0.0600 (-2.55%)
At Close: May 10, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $1.66 $2.47 Friday, 10th May 2024 PTN stock ended at $2.29. This is 2.55% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 11.76% from a day low at $2.21 to a day high of $2.47.
90 days $1.47 $4.65
52 weeks $1.43 $5.65

Historical Palatin Technologies Inc prices

Date Open High Low Close Volume
Jan 03, 2017 $0.510 $0.549 $0.510 $0.549 1 005 900
Dec 30, 2016 $0.518 $0.518 $0.502 $0.505 834 300
Dec 29, 2016 $0.520 $0.520 $0.502 $0.506 795 300
Dec 28, 2016 $0.515 $0.527 $0.494 $0.510 1 547 400
Dec 27, 2016 $0.530 $0.530 $0.510 $0.514 912 500
Dec 23, 2016 $0.531 $0.539 $0.520 $0.536 516 500
Dec 22, 2016 $0.526 $0.550 $0.504 $0.550 1 511 400
Dec 21, 2016 $0.548 $0.550 $0.513 $0.524 1 400 800
Dec 20, 2016 $0.540 $0.558 $0.536 $0.540 789 000
Dec 19, 2016 $0.549 $0.560 $0.540 $0.560 1 004 600
Dec 16, 2016 $0.550 $0.560 $0.540 $0.551 951 500
Dec 15, 2016 $0.560 $0.580 $0.525 $0.565 3 546 500
Dec 14, 2016 $0.490 $0.520 $0.460 $0.510 2 189 100
Dec 13, 2016 $0.510 $0.510 $0.453 $0.484 3 839 500
Dec 12, 2016 $0.565 $0.565 $0.490 $0.500 4 255 200
Dec 09, 2016 $0.570 $0.574 $0.533 $0.534 3 514 700
Dec 08, 2016 $0.570 $0.580 $0.550 $0.575 2 126 100
Dec 07, 2016 $0.580 $0.586 $0.562 $0.571 1 360 000
Dec 06, 2016 $0.561 $0.586 $0.560 $0.571 2 070 300
Dec 05, 2016 $0.575 $0.587 $0.571 $0.574 1 830 400
Dec 02, 2016 $0.589 $0.589 $0.565 $0.574 1 799 000
Dec 01, 2016 $0.540 $0.640 $0.540 $0.560 10 996 400
Nov 30, 2016 $0.750 $0.90 $0.750 $0.82 6 778 600
Nov 29, 2016 $0.670 $0.84 $0.655 $0.82 7 421 100
Nov 28, 2016 $0.700 $0.750 $0.632 $0.670 5 232 700
Click to get the best stock tips daily for free!

About Palatin Technologies Inc

Palatin Technologies Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatmen... PTN Profile

Golden Star

Ticker Date Change Price
SXI May 08 2.97% $173.34
NVO May 08 1.37% $126.69
PAG May 07 1.42% $153.22
WMT May 06 1.02% $59.87
UNP May 06 3.42% $239.21
JPM May 06 3.53% $192.00
INGR May 03 4.94% $114.56
ASH May 03 2.28% $95.85
INVH May 03 1.13% $34.39
INTU May 03 0.483% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT